A Focus on Effective Test Utilization to Demonstrate Lab Value in the New Healthcare Model



Similar documents
Effective Test Utilization: A Laboratory s First Step in Contributing to the New Healthcare Model

Nuts and Bolts Accountable Care Organizations: A New Care Delivery Model for New Expectations

Accountable Care Organization Workgroup Glossary

70% of medical decisions are based on lab results

Realizing ACO Success with ICW Solutions

Medweb Telemedicine 667 Folsom Street, San Francisco, CA Phone: Fax:

MaineCare Value Based Purchasing Initiative

Meaningful Use and Lab Related Requirements

Below are some of the ways pathologists contribute to the six domains (listed in the order they appear on page 2 of the Strategy):

Health Information Technology and the National Quality Agenda. Daphne Ayn Bascom, MD PhD Chief Clinical Systems Officer Medical Operations

Meaningful Use 2015 and beyond. Presented by: Anna Mrvelj EMR Training Specialist

A STRATIFIED APPROACH TO PATIENT SAFETY THROUGH HEALTH INFORMATION TECHNOLOGY

Value-Based Insurance Design. Using Smarter Cost-sharing to Align Consumer Incentives with Alternative Payment Models

Achieving Quality and Value in Chronic Care Management

Patient Centered Medical Home: An Approach for the Health Plan

InteliChart. Putting the Meaningful in Meaningful Use. Meeting current criteria while preparing for the future

ICD-10 Now What? Joseph C Nichols MD Principal. A Health Data Consulting White Paper

Automated Retinal Imaging for Enterprise Screening

Succeeding in Healthcare Risk Adjustment. A Guide for Healthcare Providers and Accountable Care Organizations

Proven Innovations in Primary Care Practice

Adding Value to. Provider Compensation. June 13, Healthcare Strategy Group OHA Presentation Adding Value to. Physician Compensation

Medicaid EHR Incentive Program

HL7 & Meaningful Use. Charles Jaffe, MD, PhD CEO Health Level Seven International. HIMSS 11 Orlando February 23, 2011

Co-management (Service Line Agreement 2007)

Value-Based Radiology

HEALTHCARE REFORM SOLUTIONS. Designing a Pharmacy Benefit for the New Public Health Exchange Consumers

Accountable Care Organizations: From Promise to Progress

Meaningful Use. Medicare and Medicaid EHR Incentive Programs

evolve and integrate a new imperative for ambulatory care

Accountable Care: Implications for Managing Health Information. Quality Healthcare Through Quality Information

Enabling Patients Decision Making Power: A Meaningful Use Outcome. Lindsey Mongold, MHA HIT Practice Advisor Oklahoma Foundation for Medical Quality

Technology and Hawaii s Independent Physician:

THE ROLE OF CLINICAL DECISION SUPPORT AND ANALYTICS IN IMPROVING LONG-TERM CARE OUTCOMES

Overview of MU Stage 2 Joel White, Health IT Now

Meaningful Use in 2015 and Beyond Changes for Stage 2

Value-Based Programs. Blue Plans Improving Healthcare Quality and Affordability through Innovative Partnerships with Clinicians

Meaningful Use Objectives

Navigating CMS Incentive Programs for Eligible Professionals Why It Matters and What You Need to Know. Dr. Paul Mulhausen, CMO

THE EVOLUTION OF CMS PAYMENT MODELS

BCBSM PG5 P4P Program Population Health Management Champion Measure

Accountable Care Platform

ACCOUNTABLE CARE ANALYTICS: DEVELOPING A TRUSTED 360 DEGREE VIEW OF THE PATIENT

Collaboration is the Key for Health Plans in a Shared Risk Environment

Summary of the Final Rule for Meaningful Use for 2015 and Meaningful Use Objectives for 2015 and 2016

Meaningful Use. Goals and Principles

RPMS EHR Remote Support and Configuration

Accountable Care Communities 101. Jennifer M. Flynn, Esq. Senior Director, State Affairs Premier healthcare alliance January 30, 2014

Meaningful Use Updates Stage 2 and 3. Julia Moore, Business Analyst SMC Partners, LLC July 8, 2015

Leadership Summit for Hospital and Post-Acute Long Term Care Providers May 12, 2015

Banner Health Network Pioneer ACO - Physician Toolkit

Population Health Management Innovation Payer and Provider Collaboration. Population Health Management Innovation Payer and Provider Collaboration

LTC Division Webinar Accountable Care Organizations and LTC Pharmacy - The New Era in Health Care Delivery

ACO s as Private Label Insurance Products

Running Head: COST-CONTROLLING MEASURES OF THE A.C.A. 1. Lesser Politicized Cost-Controlling Measures of the Affordable Care Act: Literature Review

Strengthening Medicare: Better Health, Better Care, Lower Costs Efforts Will Save Nearly $120 Billion for Medicare Over Five Years.

MEANINGFUL USE STAGE FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

Analytics and Business Intelligence

Population Health Solutions for Employers MEDIA RESOURCES

The ABCs of Population Health Management Jennifer Houlihan, MSP Director of CIN Strategy, Integration and Population Health

The electronic health record (EHR) has been a game-changer for CDI specialists.

Measuring and Assigning Accountability for Healthcare Spending

Best Practices for Implementing an EHR System

Value Based Insurance Design Key concepts & their application at HealthPartners Health Insurance Plan

Post-Acute / Ambulatory Planning. Creating the right access points along the care continuum

Meaningful Use Final Rule Update. Patti Kritzberger, RHIT, CHPS Tracey Regimbal, RHIT HIT-Quality Improvement Specialists

Transcription:

A Focus on Effective Test Utilization to Demonstrate Lab Value in the New Healthcare Model Kim Futrell, MT (ASCP) Products Marketing Manager Orchard Software Corporation Page 1

Objectives Understand the changing terrain of healthcare and the lab s role in the future of healthcare Learn why proper test utilization is becoming more important as our healthcare system changes. Review how and why tests are misordered. Discuss the important role laboratorians play in better test utilization. Explore other ideas for labs to contribute to better patient outcomes. Page 2

Audience Survey Page 3

Our Changing Healthcare Environment Page 4

Healthcare Reform PPACA PCMHs, ACOs Bundled payment plans MU PAMA Healthcare touches all of us. Work together to make improvements. Where can the lab make positive contributions? Page 5

Healthcare Costs at Nearly 18% of GDP Page 6

Shift from Volume to Value Triple Aim Goals Improve Patient Experience Improve Population Health Decrease Costs Page 7

The Lab in the New Healthcare Model Healthcare is in the midst of unprecedented change. Labs will no longer be reimbursed for each test performed. Currently in a transition between FFS and valuebased environment. Page 8

Better, Smarter, Healthier Source: HHS.org: US Department of Health & Human Services Page 9

Wrongly Aligned Incentives FFS model Creates an incentive to order more tests and more treatment. Payment is dependent on the quantity of care, rather than the quality of care. Does not support alignment of financial incentives between providers. Page 10

Lab s Evolution in Healthcare Expand your reach. Increase clinical effectiveness. Contribute to positive patient outcomes. Integrate and collaborate with other departments. Page 11

Expand the Lab s Reach Improve Testing Methodologies: MALDI TOF Radiology: POC creatinine for patients with contrast studies Pharmacy: Antibiotic stewardship - Dr. Brad Brimhall, University of Mississippi Medical Center Page 12

Support of rapid, accurate diagnosis Maximum efficiency Eliminate waste One of the most effective ways to do this is by monitoring laboratory test utilization. Lab s Future Role: Greater Impact on Patient Care Page 13

Overriding Goal Accurate Right Test Results Right Cost Cognizant Patient Test Utilization Right Time Plan Page 14

Test Utilization: How and Why Lab Tests are Misordered Page 15

Room for Improvement Laboratory testing is healthcare s highest volume activity. - 7-10 billion tests/year Increasing awareness: Errors in lab test selection and interpretation can have significant consequences. Page 16

How Providers Use Lab Tests 70-80% of clinical data in the EHR comes from the lab. Data used for: Screening Diagnosis Disease monitoring Two-thirds of results contribute to a change in diagnosis, therapy, prognosis, or understanding of a disease. - Wertman, Bradley G. MD., et. al. Why Do Physicians Order Laboratory Tests? A Study of Laboratory Test Request and Use Patterns. JAMA. 1980; 243(20):2080-2082. Page 17

Overuse, Underuse, & Misuse Nearly one-third of all lab testing is unnecessary. Approximately, the same number of tests that could potentially be useful are not ordered. Source: Beth Israel Deaconess Medical Center Labs may not be promptly reviewed or not communicated to the patient. Page 18

Costs of Lab Testing Lab portion of healthcare spending is approximately 3%. In overall costs, ordering a few more or less does not make a big difference. However, what happens to the patient downstream based on those results can be expensive (imaging, surgery, hospital stays, etc.). Page 19

The Big Take Home It s not about ordering more or less tests. It s about ordering the right tests. And in this area there is much room for improvement. And the lab can help! Page 20

Why Lab Tests are Misordered That s the way it s always been done. Pressure from internet-educated patients Page 21

Why Lab Tests are Misordered 2 Concern over missing something that can lead to litigation - or patient harm Physicians have been taught to leave no stone unturned. Page 22

The presentation of test order options influences order patterns. Providers are moving at a fastpace. Other Influential Factors Page 23

The Role of CPOE Confounded by EHR limitations Provide useful information at the time of order Pop-up (e.g., for duplicate tests) Online decision support Page 24

Page 25

Providers Uncertain CLIHC survey PCPs uncertain about best test order in 14.7% of cases. Uncertain about interpretation in 8.3% of cases. What this means Approximately 23 million times/year, PCPs are uncertain about the best use of diagnostic tests. Page 26

Overutilization $750 billion spent in U.S. on unnecessary healthcare services. 2012 IOM Report Costly tests are easy to order in the EHR With no indication of costs Or medical evidence to support use Page 27

Overutilization 2 Most frequent instance of overuse occurs at the initial patient evaluation. Beth Israel Deaconess Medical Center Study Hospital settings often have inpatient SO: convenient but wasteful Large majority of tests being ordered have no impact on patient care Univ. of CA, SF Medical Center Study Page 28

Underutilization/ Preventive Testing >70% Increased of Medicare Lab Testing $$ are is spent a vital on only 14% component of patients of early who have chronic 6 or disease more that chronic can save conditions. $$. Page 29

Underutilization Example MC Consider beneficiaries the with Hgb diabetes A1c account for 32% of MC spending. costs about $13 Source: Congressional Diabetes Caucus Page 30

Doctors Don t Turn to the Lab for Guidance Providers are aware of deficiencies in test utilization. Yet when searching for guidance, the last place they turn is to the lab. Page 31

CLIHC Survey Results % of physicians: it is useful to ask the lab for test 35% interpretation guidance % of physicians that were actually able to ask a 6% lab leader for advice Page 32

Test Utilization: Where to Start Page 33

Questions to ask Are you aware of unnecessary test requests or know of test utilization areas that can be improved upon? Do you have an LIS capable of providing the necessary tools to promote proper test utilization? What test utilization data are you able to collect? Is that data in a structured, useable format? Page 34

Questions to ask 2 Do you have provider support? At the time of the order, does the provider have algorithms and guidelines to use? Does your CPOE process include appropriate pop-up alerts, such as duplicate testing notification? Page 35

More Questions Have you unbundled tests to provide the flexibility necessary for an effective test utilization strategy? Do you review requisitions/orders and standing orders, looking for redundancy and testing frequency? Do you have an annual review process for test volumes comparing year-to-year volume shifts? Page 36

More Questions 2 Do you have a test formulary or review process for sendout testing, keeping an eye on expensive, esoteric tests? Do you have a hold process to ensure proper specimen storage until an initial test is completed and a subsequent utilization decision is made? Page 37

Page 38

Internal Variation Analysis Examine your provider ordering patterns. Focus on a specific diagnosis. Compare the amount of variation to costs and patient outcomes. Share this data with providers. Find a physician champion who is willing to be involved. Use this data to develop best practice ordering guidelines. Page 39

Source: Crystal Run Healthcare Page 40

Think Outside of the Black Box CLIHC Physician survey When consulting with radiology or pharmacy, they felt they were consulting with a colleague. When consulting with the laboratory, they felt they were talking to a black box. Using a test utilization plan can improve the laboratory s input into patient care. Page 41

Provider collaboration is a must. Create opportunities for an ongoing dialogue. Physicians respond to data. Provide Data & Dialogue Page 42

Testing Formularies Management of a test menu Page 43

Duplicate Testing Alerts Implement a duplicate testing alert in the EHR at the point of CPOE. Savings at Univ. of Mississippi Medical Center By monitoring 2 tests (CBC, BMP) Same tests ordered within a 4 hr period Saved $146,675 annualized Page 44

Johns Hopkins Bayview Reduces Overuse of Cardiac Tests Grant from ABIM Foundation Project reduced lab tests used to assess acute coronary syndrome Use Troponin alone and no more than three times. More than $1 million saved - LaRochelle, et.al. Journal of Internal Medicine, June 2014 Page 45

Unnecessary Testing Groups Determine (with your providers) scenarios where it does not make clinical sense to order certain test combinations. Do not need a test until you know results of another Another test has greater diagnostic accuracy Testing only recommended for specific diagnoses Page 46

Page 47

Testing Algorithms Provider orders the cascade, rather than each test. Based on initial results auto-reflexes to the next logical test. Develop in tandem with ordering providers. Page 49

Benefits of Testing Algorithms Eliminates the need for providers to choose from an overwhelming test menu. Ensures that only necessary tests are ordered. Getting the right test done at the right time improves patient care and reduces unnecessary spending. Page 50

Page 51

Track test utilization/ variation analysis Configure algorithms Provide data analytics for providers & managers Powerful LIS = Crucial Tool Page 52

Opportunity to Make a Difference Disruption in healthcare Opportunity for laboratory leaders to refocus efforts Align goals with overriding healthcare reform goals Thrive in a value-based reimbursement model Alleviate downstream costs Page 53

New Paradigm Make the most of limited resources Each member of the healthcare team s input to the top of their skill/ education level Lab professionals Page 54

Seek out Opportunity 1. Get to know those in your organization who have access to financial data, particularly net revenue and cost accounting figures. 2. Integrate information you have in the laboratory with information obtained from colleagues in other departments. Page 55

White Papers to Help Download at www.orchardsoft.com/whitepapers Page 56

2015 Orchard User Group & Symposium June 17 th & 18th Caribe Royale in Orlando, FL www.orchardsoft.com/symposium Page 57

Old Paradigm to New Provide utilization management, Providing clinical high-quality, effectiveness, cost-effective and data integration results - Curtis A. Hanson, MD, Mayo Clinic Page 58

It Won t Be Easy Page 59

Final Words of Wisdom Because laboratory tests play such a crucial and ubiquitous role in medicine, efforts to identify opportunities for improvement in the selection of tests have the potential to contribute greatly to the care patients receive. - William Taylor, MD, BIDMC Page 60

Page 61

Thank You Questions?